Conducting a Lung Multidisciplinary Tumor Board at the National University Cancer Institute, Singapore
By Ross Soo, MB, BS, PhD, FRACP Posted: August 21, 2020 Dr. Ross Soo Impressive progress has been achieved in many aspects of lung cancer. Over the past […] Read more
Patient Perspectives on Telehealth During COVID-19: Balancing Fear, Self-Advocacy
By Jennifer Byrne Posted: August 21, 2020 For nearly 2 decades, Bonnie Anderson has defied incredible odds in the face of mesothelioma, hairy cell leukemia, breast cancer, lung cancer, and […] Read more
By Kara Nyberg, PhD Posted: August 21, 2020 A multitude of factors contribute to disparities in lung cancer care, including sex, race, education level, income, geographic region, and access to […] Read more
An Early Look at Adjuvant Osimertinib Shows a Dramatic Improvement in Disease-Free Survival
By Mary Jo Fidler, MD Posted: August 21, 2020 At the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program Plenary Session, an early look at data from the […] Read more
By Kara Nyberg, PhD Posted: August 19, 2020 A multitude of factors contribute to disparities in lung cancer care, including sex, race, education level, income, geographic region, and access to […] Read more
Dr. Harpreet Singh Discusses the Conduct of FDA Clinical Trials During the COVID-19 Pandemic
Harpreet Singh, MD, is director of Division of Oncology 2 at the U.S. Food and Drug Administration (FDA). In the following interview, she discusses the FDA’s response to the COVID-19 […] Read more
Broad Molecular Testing in Lung Cancer: The Struggle to Translate Recommendations to Clinical Practice
By Kara Nyberg, PhD Posted: June 24, 2020 Over the past decade, lung cancer has emerged as a shining example of how precision medicine can dramatically improve patient outcomes. Up […] Read more
Evolution of Research Using Patient-Reported Outcomes in Lung Cancer: A Q&A With Dr. Benjamin Movsas
Posted: June 24, 2020 The IASLC Lung Cancer News spoke with Benjamin Movsas, MD, regarding the evolution of patient-reported outcomes (PROs) for lung cancer. Dr. Movsas is the co-chair of […] Read more
By Giovanni Luca Ceresoli, MD Posted: June 24, 2020 Dr. Giovanni Luca Ceresoli Tumor-treating fields (TTFields) are a noninvasive, regional treatment based on the delivery of low-intensity alternating electric […] Read more
By Mariano Provencio, MD, PhD Posted: June 24, 2020 Data can help inform change to standard of care, but at what point do we say enough data is enough and […] Read more